Many patients fail to respond completely to the drugs they are given, and others manifest often severe adverse effects. Obviously, a better fundamental understanding of the nature of genetic predisposition to diseases as well as drug action is essential for future progress in healthcare. Drugs may interact specifically and selectively with the genetic properties of an individual. Pharmacogenomics predicts how an individual's genetic inheritance will affect the body's response to drugs. This course will deal with fundamental concept of pharmacogenomics, its application to disease management and patient care, and future trends. P: BMS 301 or PHA 301.
Spring 2020, Spring 2019, Spring 2018, Spring 2017